Table 3.
Cohort | AD/MCI | ALS | CVD | FTD | PD | MDD | Control (MDD) | Control (ND) |
---|---|---|---|---|---|---|---|---|
Program | ONDRI | ONDRI | ONDRI | ONDRI | ONDRI | CAN-BIND | CAN-BIND | BEAM |
N | 126 | 40 | 161 | 53 | 140 | 211 | 112 | 45 |
Age, years ± SD | 71.00 ± 8.16 | 62.00 ± 8.75 | 69.17 ± 7.41 | 67.89 ± 7.05 | 67.92 ± 6.38 | 35.30 ± 12.65 | 33.04 ± 10.74 | 66.73 ± 6.04 |
Sex, % female | 45.2% | 40.0% | 31.7% | 35.8% | 22.1% | 63.0% | 63.4% | 75.6% |
Education, years ± SD | 15.09 ± 2.91 | 13.95 ± 2.44 | 14.37 ± 2.85 | 13.66 ± 2.61 | 15.31 ± 2.62 | 14.10 ± 2.07 | 15.65 ± 2.25 | 16.31 ± 2.03 |
QIDS-SR total ± SD | 3.93 ± 3.12 | 6.28 ± 3.70* | 4.27 ± 3.11 | 5.36 ± 4.07* | 5.61 ± 3.28* | 14.92 ± 3.76* | 2.27 ± 1.94 | 3.04 ± 2.11 |
GAD-7 total ± SD | 2.30 ± 3.60 | 3.30 ± 4.21 | 2.58 ± 3.90 | 2.72 ± 3.71 | 3.24 ± 4.11 | 11.79 ± 5.02* | 0.89 ± 1.73 | 1.04 ± 1.82 |
Significantly different than controls (p < 0.05).